124 related articles for article (PubMed ID: 8398263)
1. Ploidy and proliferative index in medulloblastoma: useful prognostic factors?
Tait DM; Eeles RA; Carter R; Ashley S; Ormerod MG
Eur J Cancer; 1993; 29A(10):1383-7. PubMed ID: 8398263
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in medulloblastoma, including DNA ploidy.
Zerbini C; Gelber RD; Weinberg D; Sallan SE; Barnes P; Kupsky W; Scott RM; Tarbell NJ
J Clin Oncol; 1993 Apr; 11(4):616-22. PubMed ID: 8478656
[TBL] [Abstract][Full Text] [Related]
3. Relation of tumor-cell ploidy to survival in children with medulloblastoma.
Gajjar AJ; Heideman RL; Douglass EC; Kun LE; Kovnar EH; Sanford RA; Fairclough DL; Ayers D; Look AT
J Clin Oncol; 1993 Nov; 11(11):2211-7. PubMed ID: 8229136
[TBL] [Abstract][Full Text] [Related]
4. DNA content--a prognostic factor in childhood medulloblastoma?
Mandel M; Toren A; Nativ O; Rechavi G; Neumann Y; Nass D; Mor Y
Acta Oncol; 1993; 32(6):691-2. PubMed ID: 8260190
[No Abstract] [Full Text] [Related]
5. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA analysis of medulloblastoma. Prognostic implication of aneuploidy.
Tomita T; Yasue M; Engelhard HH; McLone DG; Gonzalez-Crussi F; Bauer KD
Cancer; 1988 Feb; 61(4):744-9. PubMed ID: 3338037
[TBL] [Abstract][Full Text] [Related]
7. Mitotic percentage index: a new prognostic factor for childhood medulloblastoma.
Gilbertson RJ; Jaros E; Perry RH; Kelly PJ; Lunec J; Pearson AD
Eur J Cancer; 1997 Apr; 33(4):609-15. PubMed ID: 9274443
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients.
Chou PM; Reyes-Mugica M; Barquin N; Yasuda T; Tan X; Tomita T
Pediatr Neurosurg; 1995; 23(6):283-91; discussion 291-2. PubMed ID: 8743996
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of DNA ploidy in medulloblastoma of childhood.
Yasue M; Tomita T; Engelhard H; Gonzalez-Crussi F; McLone DG; Bauer KD
J Neurosurg; 1989 Mar; 70(3):385-91. PubMed ID: 2915244
[TBL] [Abstract][Full Text] [Related]
10. C-MYC expression in medulloblastoma and its prognostic value.
Herms J; Neidt I; Lüscher B; Sommer A; Schürmann P; Schröder T; Bergmann M; Wilken B; Probst-Cousin S; Hernáiz-Driever P; Behnke J; Hanefeld F; Pietsch T; Kretzschmar HA
Int J Cancer; 2000 Sep; 89(5):395-402. PubMed ID: 11008200
[TBL] [Abstract][Full Text] [Related]
11. Biologic risk stratification of medulloblastoma: the real time is now.
Fisher PG; Burger PC; Eberhart CG
J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
[No Abstract] [Full Text] [Related]
12. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
13. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.
Banfield E; Brown AL; Peckham EC; Rednam SP; Murray J; Okcu MF; Mitchell LE; Chintagumpala MM; Lau CC; Scheurer ME; Lupo PJ
Cancer Epidemiol; 2016 Oct; 44():161-166. PubMed ID: 27607585
[TBL] [Abstract][Full Text] [Related]
14. Bone metastases of medulloblastoma in childhood; correlation with flow cytometric DNA analysis.
Tomita T; Das L; Radkowski MA
J Neurooncol; 1990 Apr; 8(2):113-20. PubMed ID: 2358845
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas.
Wijnaendts LC; van der Linden JC; van Diest P; van Unnik AJ; Delemarre JF; Voûte PA; Meijer CJ
J Clin Pathol; 1993 Oct; 46(10):948-52. PubMed ID: 8227415
[TBL] [Abstract][Full Text] [Related]
16. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.
Leal LF; Evangelista AF; de Paula FE; Caravina Almeida G; Carloni AC; Saggioro F; Stavale JN; Malheiros SMF; Mançano B; de Oliveira MA; Luu B; Neder L; Taylor MD; Reis RM
Neuropathology; 2018 Oct; 38(5):475-483. PubMed ID: 30155928
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study of prognostic value of DNA ploidy and proliferative activity in neuroblastoma.
Huddart SN; Muir KR; Parkes SE; Mann JR; Stevens MC; Raafat F; Smith K
J Clin Pathol; 1993 Dec; 46(12):1101-4. PubMed ID: 8282832
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma: survey of factors possibly influencing the prognosis.
Müller W; Afra D; Schröder R; Slowik F; Wilcke O; Klug N
Acta Neurochir (Wien); 1982; 64(3-4):215-24. PubMed ID: 7136866
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in medulloblastoma.
Chin HW; Maruyama Y
Am J Clin Oncol; 1982 Aug; 5(4):359-69. PubMed ID: 6810689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
